Research
Metabolic adaptation
Endoluminal bariatric and metabolic therapies have expanded significantly, with FDA-approved therapies available for patients with a body mass index as high as 50 kg/m².
Practitioners should consider these therapies for patients with high BMI who may not qualify for traditional bariatric surgery.
StrongSupportsmedium confidence
The landscape of endoluminal devices and techniques for treating obesity has expanded significantly, with FDA-approved therapies currently available to patients with a body mass index values as high as 50 kg/m 2.
Why this rating
The abstract summarizes a review of current therapies, indicating a comprehensive overview.
Source
Endoluminal bariatric and metabolic therapies: state-of-the-art
Nader Bakheet et al. · Current Opinion in Gastroenterology · 2023
reviewCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →